BOCA RATON, Fla.–(BUSINESS WIRE)–November 12, 2013–
Zero Gravity Solutions, Inc. (ZGSI or “the Company”), (Pink Sheets: ZGSI), announced today that Dr. Anthony J. (Tony) Tether, former Director of the Defense Advanced Research Projects Agency (DARPA), has been appointed Senior Strategic Advisor to the Company. In this role, he will provide the Company’s senior management and board of directors the benefit of his experience in bringing advanced, breakthrough technologies to scale and deployment. He will offer his guidance on the implementation of ZGSI’s core business mission of utilizing the Company’s technologies developed for the space program to address the threat to humanity in feeding the world in the face of population growth and threats to the world’s food crops.
Harvey Kaye, Chairman of the Company, stated, “Given Tony’s involvement with early technologies such as GPS, which had worldwide applications and implications, his perspective and insight into the challenges and opportunities of introducing disruptive technologies will prove invaluable to the Company.”
Richard Godwin, Chief Executive Officer and President of ZGSI, stated, “The scope of our Company’s activities requires interaction with the space, scientific, academic and other related communities. Tony’s experience as DARPA’s longest serving director will provide perspective and strategic insights vital to achieving our company’s goals.”
Tony Tether, ZGSI’s newly appointed Senior Strategic Advisor, stated, “In my opinion Zero Gravity Solutions has pulled together an exceptional team for addressing how to use the knowledge gained through space efforts for significantly increasing the yield and nutritional value of food crops, and the knowledge gained from zero gravity on biological innovations in areas such as stem cells. I felt that this team has a high probability of commercializing this knowledge. I am pleased to be part of it and feel that I can help them select and create project plans that get to the bottom line sooner rather than later, thereby increasing near term value to the shareholders.”
About Zero Gravity Solutions, Inc.
Zero Gravity Solutions, Inc. is a zero gravity biotechnology company whose mission is to improve life on earth by using technology designed for and derived from space and through utilization of the unique long-term microgravity environment platform of the International Space Station (ISS). The Company’s initial projects will be directed to providing solutions to critical world food crops challenges. The Company owns proprietary technology for its first commercial product, BAM-FXTM that can boost the nutritional value and enhance the immune system of food crops without the use of Genetic Modification. Further, the Company is focused on industrializing and commercializing scientific breakthroughs in the area of patentable stem cell technologies through developing advances in plant, animal and human biology based on intellectual property designed for and derived from multiple experiments on the ISS. The Company owns intellectual property that is designed to develop and produce, in a microgravity environment and without Genetic Modification techniques, large volumes of novel stem cells with unique and beneficial characteristics, which can be patented for commercial sale to third parties in the agricultural and human regenerative medical markets. ZGSI is headquartered in Boca Raton, Florida with offices and/or operations in Naperville, Illinois and Stevensville, Maryland. Information on the Company can be viewed on www.zerogsi.com.
This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, acceptance of the Company’s products, increased levels of competition for the Company, new products and technological changes, the Company’s dependence on third-party suppliers, and other risks detailed from time to time in the Company’s periodic reports filed with the Securities and Exchange Commission.